‘Ivejaj’ Tablets for COVID-19 Treatment

Current Context: Bajaj Healthcare Limited has announced the launch of ‘Ivejaj’ (Ivermectin) which is an Anti-Parasitic Drug used in control & offers treatment for Covid-19 patients.

• The company has also received approval from India's drug regulator, DCGI to manufacture and market ‘Ivejaj’.
• Bajaj Healthcare Limited has developed the active pharmaceutical ingredient and the formulation for Ivermectin through its R&D team.

Question: 

Q.1 Which organisation developed ‘Ivejaj’ (Ivermectin) which is an Anti-Parasitic Drug used in control & offers treatment for Covid-19 patients?
a. Syncom Healthcare
b. Eris Lifesciences
c. Bajaj Healthcare Limited
d. Parabolic Drugs Ltd.